Tabuchi N, Akasaki K, Tsuji H
Faculty of Pharmacy and Pharmaceutical Sciences, Fukuyama University, Fukuyama, Hiroshima, 729-0292, Japan.
Biochem Biophys Res Commun. 2000 Apr 13;270(2):557-63. doi: 10.1006/bbrc.2000.2448.
Lysosomal membrane glycoprotein termed LGP85 or LIMP II has a COOH-terminal cytoplasmic tail whose amino acid sequence is R(459)GQGSMDEGTADERAPLIRT(478). Two acidic amino acid residues, D(470) and E(471), in the cytoplasmic tail of LGP85 are crucial for its binding to adaptor-like complex AP-3. In the present study we investigated their role(s) in intracellular distributions of LGP85 using two alanine substitution mutants at D(470) and E(471) (defined as D470A and E471A, respectively). Immunofluorescence analysis showed that D470A and E471A are localized to endocytic organelles as well as wild-type LGP85. However, the subcellular fractionation study revealed that D470A and E471A are different from wild-type LGP85 in the distribution among early endosomes, late endosomes, and lysosomes. A major portion of wild-type LGP85 existed in the densest lysosomal fraction. In contrast, a significant amount of D470A existed in the early endosomal fraction with a light buoyant density, while less D470A resided in the lysosomal fraction. E471A broadened from the early endosomal fraction to the lysosomal fraction without the high lysosomal peak. These findings indicate that the two acidic residues, D(470) and E(471), play an important role in regulation of LGP85 movement within the endocytic pathway, which finally makes the highest concentration of LGP85 in the dense secondary lysosomes.
一种名为LGP85或LIMP II的溶酶体膜糖蛋白具有一个COOH末端细胞质尾巴,其氨基酸序列为R(459)GQGSMDEGTADERAPLIRT(478)。LGP85细胞质尾巴中的两个酸性氨基酸残基D(470)和E(471)对于其与衔接蛋白样复合物AP-3的结合至关重要。在本研究中,我们使用D(470)和E(471)处的两个丙氨酸替代突变体(分别定义为D470A和E471A)研究了它们在LGP85细胞内分布中的作用。免疫荧光分析表明,D470A和E471A与野生型LGP85一样定位于内吞细胞器。然而,亚细胞分级分离研究表明,D470A和E471A在早期内体、晚期内体和溶酶体之间的分布与野生型LGP85不同。野生型LGP85的大部分存在于密度最高的溶酶体部分。相比之下,大量的D470A存在于低密度的早期内体部分,而存在于溶酶体部分的D470A较少。E471A从早期内体部分扩展到溶酶体部分,没有高溶酶体峰。这些发现表明,两个酸性残基D(470)和E(471)在调节LGP85在内吞途径中的移动中起重要作用,最终使LGP85在致密的次级溶酶体中浓度最高。